Evaluation of antisense oligonucleotide loaded chitosan nanoparticles; characterization and antisense effect

被引:1
作者
Ozbas-Turan, S. [1 ]
Akbuga, J. [1 ]
Enneli, B. [2 ]
机构
[1] Marmara Univ, Fac Pharm, Dept Pharmaceut Biotechnol, TR-34668 Istanbul, Turkey
[2] Yeditepe Univ, Fac Pharm, Istanbul, Turkey
来源
PHARMAZIE | 2009年 / 64卷 / 12期
关键词
POLYALKYLCYANOACRYLATE NANOPARTICLES; GENE DELIVERY; FORMULATION; SYSTEM; INHIBITION; CARRIERS; DNA;
D O I
10.1691/ph.2009.9193
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The objective of this study was to investigate the effect of different formulation parameters [i.e. molecular weight and concentration of chitosan, concentration of tripolyphosphate (TPP) and use of alginate] on physico chemical and antisense properties of antisense oligonucleotide (AsODN) loaded chitosan nanoparticles (NPs). Preparation methods of phosphodiester (PO) and phosphorothioate (PS) AsODNs-NPs were also compared. AsODNI was designed to target the beta-galactosidase (beta-gal) gene. HeLa cells were used for in vitro transfection studies and beta-gal was assayed spectrophotometrically. AsODN-NPs obtained were in general positively charged with size between 221.4-525.7 nm depending on formulation. Encapsulation efficiency of NPs depended on the type of backbone of the AsODN. PO-AsODN encapsulation into NPs (78-94%) was less efficient than PS encapsulation (91-98%). The pH of the chitosan solution affected AsODN entrapment. PO-NPs exhibited faster AsODN release than NPs containing PS. In general higher beta-gal inhibition was obtained after transfection of AsODN-NPs in cell culture studies. PS-NPs exhibited a higher inhibition effect and the highest (90.71%) inhibition was obtained with formulation PT-2. PS-adsorbed NPs showed an 88% reduction in beta-gal. This study can form the basis for forthcoming in vivo studies related to AsODN carrier systems that will use chitosan.
引用
收藏
页码:807 / 811
页数:5
相关论文
共 23 条
  • [1] The delivery of antisense therapeutics
    Akhtar, S
    Hughes, MD
    Khan, A
    Bibby, M
    Hussain, M
    Nawaz, Q
    Double, J
    Sayyed, P
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2000, 44 (01) : 3 - 21
  • [2] PLGA-PEI nanoparticles for gene delivery to pulmonary epithelium
    Bivas-Benita, M
    Romeijn, S
    Junginger, HE
    Borchard, G
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2004, 58 (01) : 1 - 6
  • [3] Chitosan and chitosan ethylene oxide propylene oxide block copolymer nanoparticles as novel carriers for proteins and vaccines
    Calvo, P
    RemunanLopez, C
    VilaJato, JL
    Alonso, MJ
    [J]. PHARMACEUTICAL RESEARCH, 1997, 14 (10) : 1431 - 1436
  • [4] CALVO P, 1998, P WORLD M APGI APV, V2, P1111
  • [5] POLYALKYLCYANOACRYLATE NANOPARTICLES AS POLYMERIC CARRIERS FOR ANTISENSE OLIGONUCLEOTIDES
    CHAVANY, C
    LEDOAN, T
    COUVREUR, P
    PUISIEUX, F
    HELENE, C
    [J]. PHARMACEUTICAL RESEARCH, 1992, 9 (04) : 441 - 449
  • [6] Chitosan-TPP nanoparticle as a release system of antisense oligonucleotide in the oral environment
    Dung, Tran Huu
    Lee, Seung-Rok
    Han, Suhk-Dong
    Kim, Seon-Jeong
    Ju, Yeon-Mi
    Kim, Myong-Soo
    Yoo, Hoon
    [J]. JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY, 2007, 7 (11) : 3695 - 3699
  • [7] Emile C, 1996, Drug Deliv, V3, P187, DOI 10.3109/10717549609029449
  • [8] ENNELI B, 2007, 3 ANN M OL THER SOC
  • [9] LIPOSOME-ENTRAPPED AMPICILLIN IN THE TREATMENT OF EXPERIMENTAL MURINE LISTERIOSIS AND SALMONELLOSIS
    FATTAL, E
    ROJAS, J
    YOUSSEF, M
    COUVREUR, P
    ANDREMONT, A
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (04) : 770 - 772
  • [10] Biodegradable polyalkylcyanoacrylate nanoparticles for the delivery of oligonucleotides
    Fattal, E
    Vauthier, C
    Aynie, I
    Nakada, Y
    Lambert, G
    Malvy, C
    Couvreur, P
    [J]. JOURNAL OF CONTROLLED RELEASE, 1998, 53 (1-3) : 137 - 143